Literature DB >> 32195025

Administration of trastuzumab with heart irradiation induced acute cardiotoxicity in mice.

Peiqiang Yi1, Huan Li1, Yuehua Fang2, Jun Su1, Cheng Xu1, Lu Cao1, Min Li1, Jiayi Chen1.   

Abstract

Cardiac toxicity is one of the major advese effect associated with thoracic irradiation. Breast cancer patients with human epidermal factor receptor-2 (Her-2) overexpression could be indicated for both radiation and anti-Her2 target therapy. We aimed to investigate the early detection of radiation and Trastuzumab (TRZ) induced acute cardiotoxicity in mice. In the present study, the heart of animal was subjected to irradiation (IR, 14 Gy/1 Fx), TRZ was intraperitonealy (i.p.) administrated to mice in 2 weeks (6 fractions). The IR plus TRZ group received heart IR after TRZ. We found that body weight of mouse in treatment groups reduced significantly as compared with that of mouse in control group (P<0.05). At day 21, the diastolic function of mice decreased significantly in IR plus TRZ group compared with control group measured by E/E' parameter using echocardiography (57.72 vs 40.82, P<0.05). The left ventricular posterior wall (LVPW) and interventricular septum (IVS) were also increased significantly in diastolic phase at day 21 in the combined group compared with TRZ alone (LVPW: 0.95 mm vs 0.70 mm, P<0.05; IVS: 0.94 mm vs 0.65 mm P<0.05). Moreover, hematoxylin and eosin (HE) staining of cardiac tissue showed that the arrangement of myocardial cell was disordered in the combined group with vacuolar and adipocyte changes, as well as the loose of structure of myocardial cells and the pyknosis of the nucleus. Moderate damage was observed in irradiation-treated group and TRZ-treated group. The expressions of γ-H2AX, vascular cell adhesion molecule-1 (VCAM-1) and von Willebrand Factor (vWF) were remarkedly appeared in co-treatment group. Heart irradiation combined with TRZ treatment simultaneously might cause acute cardiac toxicity in terms of the parameter of E/E', LVPW and IVS. Our results suggest that the diastolic function could detect the early stage of acute cardiotoxicity in heart exposed to irradiation and TRZ co-treatment in mice. The DNA injury and microangiopathy might involve in cardiac injury that aggravated by radiation and Trastuzumab treatments. AJCR
Copyright © 2020.

Entities:  

Keywords:  Trastuzumab; cardiotoxcity; echocardiography; radiation

Year:  2020        PMID: 32195025      PMCID: PMC7061744     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  19 in total

Review 1.  Potential targets for intervention in radiation-induced heart disease.

Authors:  M Boerma; M Hauer-Jensen
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

2.  ERBB2 inhibition and heart failure.

Authors:  Gregory M Cote; Douglas B Sawyer; Bruce A Chabner
Journal:  N Engl J Med       Date:  2012-11-29       Impact factor: 91.245

3.  The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study.

Authors:  Hart A Goldhar; Andrew T Yan; Dennis T Ko; Craig C Earle; George A Tomlinson; Maureen E Trudeau; Murray D Krahn; Monika K Krzyzanowska; Raveen S Pal; Christine Brezden-Masley; Scott Gavura; Kelly Lien; Kelvin K W Chan
Journal:  J Natl Cancer Inst       Date:  2015-10-16       Impact factor: 13.506

Review 4.  Heart to heart with trastuzumab: a review on cardiac toxicity.

Authors:  Serena Di Cosimo
Journal:  Target Oncol       Date:  2011-11-29       Impact factor: 4.493

5.  Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways.

Authors:  Leo I Gordon; Michael A Burke; Amareshwar T K Singh; Sheila Prachand; Elliot D Lieberman; Lin Sun; Tejaswitha Jairaj Naik; Sathyamangla V Naga Prasad; Hossein Ardehali
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

6.  Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow.

Authors:  Aubrey Bernardo; Chalmette Ball; Leticia Nolasco; Joel F Moake; Jing-fei Dong
Journal:  Blood       Date:  2004-03-16       Impact factor: 22.113

7.  Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer.

Authors:  Tomoya Kitani; Sang-Ging Ong; Chi Keung Lam; June-Wha Rhee; Joe Z Zhang; Angelos Oikonomopoulos; Ning Ma; Lei Tian; Jaecheol Lee; Melinda L Telli; Ronald M Witteles; Arun Sharma; Nazish Sayed; Joseph C Wu
Journal:  Circulation       Date:  2019-05-21       Impact factor: 29.690

8.  Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab.

Authors:  Lu Cao; Gang Cai; Cai Chang; Zhao-Zhi Yang; Yan Feng; Xiao-Li Yu; Jin-Li Ma; Jiong Wu; Xiao-Mao Guo; Jia-Yi Chen
Journal:  Oncotarget       Date:  2016-01-05

Review 9.  Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography.

Authors:  Hyungseop Kim; Woo-Baek Chung; Kyoung Im Cho; Bong-Joon Kim; Jeong-Sook Seo; Seong-Mi Park; Hak Jin Kim; Ju-Hee Lee; Eun Kyoung Kim; Ho-Joong Youn
Journal:  J Cardiovasc Ultrasound       Date:  2018-03-28

10.  Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis.

Authors:  Anne Julienne Genuino; Usa Chaikledkaew; Due Ong The; Thanyanan Reungwetwattana; Ammarin Thakkinstian
Journal:  Expert Rev Clin Pharmacol       Date:  2019-07-09       Impact factor: 5.045

View more
  3 in total

1.  Trastuzumab aggravates radiation induced cardiotoxicity in mice.

Authors:  Peiqiang Yi; Huan Li; Jun Su; Jialin Cai; Cheng Xu; Jiayi Chen; Lu Cao; Min Li
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 2.  Preparation and Evaluation of Animal Models of Cardiotoxicity in Antineoplastic Therapy.

Authors:  Chenchen Meng; Lu Fan; Xiaoming Wang; Yunjiao Wang; Yanyang Li; Shuchao Pang; Shichao Lv; Junping Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-07-05       Impact factor: 7.310

3.  Pyrrolidine Dithiocarbamate Might Mitigate Radiation-Induced Heart Damage at an Early Stage in Rats.

Authors:  Yajing Wu; Lina Liu; Shengliang Lv; Yi Wang; Shuai Wang; Sheng Wang; Jiandong Zhang; Jun Wang
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.